On the day the Islamic State overran the Iraqi city of Mosul in 2014, it laid claim to one of the greatest weapons bonanzas ever to fall to a terrorist group: a large metropolis dotted with military bases and garrisons stocked with guns, bombs, rockets and even battle tanks.
But the most fearsome weapon in Mosul on that day was never used by the terrorists. Only now is it becoming clear what happened to it.
Locked away in a storage room on a Mosul college campus were two caches of cobalt-60, a metallic substance with lethally high levels of radiation. When contained within the heavy shielding of a radiotherapy machine, cobalt-60 is used to kill cancer cells. In terrorists’ hands, it is the core ingredient of a “dirty bomb,” a weapon that could be used to spread radiation and panic.
You've reached your daily free article limit.
Subscribe and support our veteran writing staff to continue reading.
On the day the Islamic State overran the Iraqi city of Mosul in 2014, it laid claim to one of the greatest weapons bonanzas ever to fall to a terrorist group: a large metropolis dotted with military bases and garrisons stocked with guns, bombs, rockets and even battle tanks.
But the most fearsome weapon in Mosul on that day was never used by the terrorists. Only now is it becoming clear what happened to it.
Locked away in a storage room on a Mosul college campus were two caches of cobalt-60, a metallic substance with lethally high levels of radiation. When contained within the heavy shielding of a radiotherapy machine, cobalt-60 is used to kill cancer cells. In terrorists’ hands, it is the core ingredient of a “dirty bomb,” a weapon that could be used to spread radiation and panic.
Western intelligence agencies were aware of the cobalt and watched anxiously for three years for signs that the militants might try to use it.
Read the whole story from The Washington Post.
Featured image courtesy of AP
Join SOFREP for insider access and analysis.
TRY 14 DAYS FREEAlready a subscriber? Log In
COMMENTS
You must become a subscriber or login to view or post comments on this article.